Focused ultrasound versus observation for low-grade cervical changes
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares two approaches for low-grade cervical changes (LSIL or CIN1) in women with high-risk HPV: treatment with a focused ultrasound (HIFU) versus simply watching and waiting. The goal is to see which approach is better at helping the body clear the abnormal cells while avoiding unnecessary treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman (18 or older) who still has menstrual periods.
- You have tested positive for a high-risk type of HPV.
- You have had a biopsy that confirms low-grade cervical changes (called LSIL or CIN1).
- You are not pregnant or breastfeeding at the time of treatment.
- You have not had prior treatment for cervical pre-cancer or cervical cancer.
- You are able to attend follow-up appointments and do not have serious medical conditions that would interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial tests whether high-intensity focused ultrasound (a targeted heat treatment) can treat some types of breast tumors and potentially reduce the need for more invasive surgery. It may help people who have specific tumor features and who are able to safely undergo MRI and the required positioning.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
This study tests a new treatment (NWRD08) for women with high-grade cervical changes (CIN 2/3) caused by HPV types 16 or 18. It aims to see if the treatment can help clear the abnormal cells and prevent them from becoming cancer.
This study is testing a decision-making tool to help doctors choose the best care for women with small fibroids that cause no symptoms. It also looks at factors that may affect outcomes when using HIFU, a non-surgical treatment that heats tissue with focused ultrasound.
Hear when a new HPV Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.